Edition:
United States

Profile: GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,395.80INR
18 Aug 2017
Change (% chg)

Rs3.25 (+0.14%)
Prev Close
Rs2,392.55
Open
Rs2,387.00
Day's High
Rs2,400.00
Day's Low
Rs2,362.00
Volume
6,629
Avg. Vol
9,759
52-wk High
Rs3,323.00
52-wk Low
Rs2,201.20

GlaxoSmithKline Pharmaceuticals Limited is a pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in approximately three areas, including pharmaceuticals, vaccines and consumer healthcare. The Company's product portfolio includes prescription medicines and vaccines. The Company's prescription medicines range across therapeutic areas, and it also offers a range of vaccines for prevention of life-threatening diseases, such as pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough, small pox and influenza. It provides healthcare solutions to patients, with a range of prescription medicines across areas covering anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The Company's manufacturing unit is located at Nashik, and its clinical development center is located in Bangalore.

Company Address

GlaxoSmithKline Pharmaceuticals Ltd

Dr Annie Besant Road, Worli
MUMBAI     400030
P: +9122.24959595
F: +9122.24959494

Company Web Links